HB 223 - AS INTRODUCED
2023 SESSION
23-0392
05/08
HOUSE BILL 223
AN ACT relative to prescription refills.
SPONSORS: Rep. D. McGuire, Merr. 14; Rep. Merchant, Sull. 6
COMMITTEE: Health, Human Services and Elderly Affairs
-----------------------------------------------------------------
ANALYSIS
This bill creates an exception to the 34-day limit on prescription refills of schedule III topical androgens if the prescription specifies it is being used for the treatment of chronic low testosterone replacement therapy.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
23-0392
05/08
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Twenty Three
AN ACT relative to prescription refills.
Be it Enacted by the Senate and House of Representatives in General Court convened:
1 Controlled Drugs; Sale by Pharmacists. Amend RSA 318-B:9, IV to read as follows:
IV. No prescription shall be filled for more than a 34-day supply upon any single filling for controlled drugs of schedules II or III; provided, however, that for controlled drugs, in schedules II or III, that are commercially packaged for dispensing directly to the patient, such as metered sprays and inhalers, liquids packaged in bottles with calibrated droppers, and certain topical preparations packaged with metered dispensing pumps may be filled for greater than a 34-day supply, but not more than 60 days, utilizing the smallest available product size, in order to maintain the dosing integrity of the commercially packaged containers; and, provided that:
(a) With regard to amphetamines and methylphenidate hydrochloride, a prescription may be filled for up to a 90-day supply if either such prescription specifies it is being used for the treatment of attention deficit disorder, attention deficit disorder with hyperactivity, or narcolepsy; and
(b) With regard to a topically applied androgen, a prescription may be filled for up to a 90-day supply if the prescription specifies it is being used for the treatment of chronic low testosterone replacement therapy.
2 Effective Date. This act shall take effect January 1, 2024.